Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Q32 Bio ( (QTTB) ) has issued an update.
On December 17, 2025, Q32 Bio Inc. announced that board member Mark Iwicki, who had previously notified the company of his intention to resign from its Board of Directors effective December 31, 2025, withdrew that resignation after a reduction in the number of boards on which he serves. With the full support of the board, Iwicki will remain Chair of the Board and the Compensation Committee, as well as a member of the Audit Committee, preserving leadership continuity and stability in Q32 Bio’s governance structure.
The most recent analyst rating on (QTTB) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Q32 Bio stock, see the QTTB Stock Forecast page.
Spark’s Take on QTTB Stock
According to Spark, TipRanks’ AI Analyst, QTTB is a Neutral.
Q32 Bio’s overall stock score is low due to significant financial instability, negative revenue, and ongoing losses. The technical analysis shows mixed signals, while the valuation is unattractive with a negative P/E ratio and no dividends. These factors highlight the company’s current financial and operational challenges, suggesting a need for strategic changes to improve its financial health.
To see Spark’s full report on QTTB stock, click here.
More about Q32 Bio
Average Trading Volume: 3,084,238
Technical Sentiment Signal: Sell
Current Market Cap: $35.44M
Find detailed analytics on QTTB stock on TipRanks’ Stock Analysis page.